Triple
T23417459
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Bristol Myers Squibb |
E560549
|
entity |
| Predicate | product |
P490
|
FINISHED |
| Object | Abecma |
—
|
NE NERFINISHED |
How this triple was built (2 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Abecma | Statement: [Bristol Myers Squibb, product, Abecma]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Abecma Context triple: [Bristol Myers Squibb, product, Abecma]
-
A.
Kymriah
chosen
Kymriah is a pioneering CAR-T cell therapy used to treat certain types of blood cancers by genetically modifying a patient’s own immune cells to target and destroy malignant cells.
-
B.
Onpattro
Onpattro is an RNA interference (RNAi) therapeutic used to treat polyneuropathy in adults with hereditary transthyretin-mediated (hATTR) amyloidosis.
-
C.
Ultomiris
Ultomiris is a long-acting monoclonal antibody therapy used to treat rare complement-mediated blood disorders such as paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome.
-
D.
BCMA
BCMA (B-cell maturation antigen) is a cell-surface protein expressed on plasma cells and multiple myeloma cells that serves as a key target for immunotherapies such as CAR T-cell treatments.
-
E.
Abellion
Abellion is a Celtic deity, likely associated with the sun or light, venerated in the region of ancient Aquitania.
- F. None of above.
- G. Unsure - the case is ambiguous/there is not enough information to decide.
Provenance (2 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69e2454cb1108190ab21ada5411a7146 |
completed | April 17, 2026, 2:35 p.m. |
| NER | Named-entity recognition | batch_69f1a516d158819081e9710b4e372a21 |
completed | April 29, 2026, 6:28 a.m. |
Created at: April 17, 2026, 5:39 p.m.